Ovation Science Inc.
OVAT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 42.67% | 81.22% | 34.86% | -10.81% | -56.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.67% | 81.22% | 34.86% | -10.81% | -56.81% |
| Cost of Revenue | -81.25% | 47.45% | 1,304.76% | 1,040.00% | 1,700.00% |
| Gross Profit | 253.85% | 95.64% | -10.34% | -42.96% | -83.80% |
| SG&A Expenses | -35.03% | -31.98% | -12.44% | -14.41% | -7.35% |
| Depreciation & Amortization | -58.33% | -33.33% | -8.33% | -25.00% | -42.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -37.61% | -29.44% | -17.16% | -18.59% | -8.77% |
| Operating Income | 44.16% | 38.36% | 22.88% | 19.69% | -0.36% |
| Income Before Tax | 53.67% | 45.64% | 19.91% | 18.79% | -9.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 53.67% | 45.64% | 19.91% | 18.79% | -9.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 53.67% | 45.64% | 19.91% | 18.79% | -9.57% |
| EBIT | 44.16% | 38.36% | 22.88% | 19.69% | -0.36% |
| EBITDA | 44.25% | 38.45% | 22.94% | 19.66% | -0.69% |
| EPS Basic | 57.50% | 51.47% | 29.50% | 24.63% | -3.09% |
| Normalized Basic EPS | 58.59% | 52.31% | 28.57% | 22.83% | -5.79% |
| EPS Diluted | 57.50% | 51.47% | 29.50% | 24.63% | -3.09% |
| Normalized Diluted EPS | 58.59% | 52.31% | 28.57% | 22.83% | -5.79% |
| Average Basic Shares Outstanding | 6.94% | 10.53% | 12.32% | 7.32% | 7.32% |
| Average Diluted Shares Outstanding | 6.94% | 10.53% | 12.32% | 7.32% | 7.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |